| abstract |
The invention relates to the use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-ones, in addition to their pharmacologically compatible salts and acid addition salts for producing medicaments, which exhibit an inhibiting action on pancreatic lipase, PL. The invention relates to the use of compounds of formula (I), in which the groups are defined as cited, in addition to their pharmacologically compatible salts and acid addition salts for producing a medicament for the prophylaxis or treatment of obesity or diabetes mellitus type 1 and 2. |